In summary, treatment of mouse models of diabetes with IL-1β- and TNF-antagonists, and with sodium salicylate improved insulin secretion and glycaemia to comparable levels, with an additive effect on insulin secretion with the combination of IL-1β- and TNFα-antagonists. This evidence concerns the gene INS and diabetes mellitus.